Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases
about
Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera from Subjects Dosed with the Anti-C1s Monoclonal Antibody TNT009 - Results from a Randomized First-in-Human Phase 1 Trial.Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity.Transcriptome Analysis of the Innate Immunity-Related Complement System in Spleen Tissue of Ctenopharyngodon idella Infected with Aeromonas hydrophila.Can Cell Bound Complement Activation Products Predict Inherited Complement Deficiency in Systemic Lupus Erythematosus?Association between C4, C4A, and C4B copy number variations and susceptibility to autoimmune diseases: a meta-analysis.The complement system as a potential therapeutic target in rheumatic disease.Novel Evasion Mechanisms of the Classical Complement Pathway.Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases.Cell-bound complement activation products in SLE.Autoantibodies against complement components in systemic lupus erythematosus - role in the pathogenesis and clinical manifestations.Effects of a Carob-Pod-Derived Sweetener on Glucose Metabolism.The Complement System and C1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia.The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus.Essential Roles for Mannose-Binding Lectin-Associated Serine Protease-1/3 in the Development of Lupus-Like Glomerulonephritis in MRL/lpr Mice.Monogenic Lupus: A Developing Paradigm of Disease
P2860
Q30491939-550AAFDA-14FE-4785-BF90-DD5FABE2B445Q33731305-6E4F60F3-395F-4E7F-9982-7D678F564CE3Q36069005-6897F735-4AA0-4D92-B5C5-BBF536F3C42BQ37542598-4122019A-5AE7-4DAE-90EE-6DF80E57B823Q37644167-F34815FB-FDEC-4709-AB5C-991339430EFCQ38631542-B419F00F-A1CC-4F3E-8A02-47464492FC96Q38824720-F4BCF2F4-CEB3-4A46-AB1C-005DF0F15AA8Q38966512-BD4D16D0-8046-46DE-B112-9E7A4250B3D4Q39450682-1BC0393E-C545-407E-B5F1-2D1F7557E3F5Q46459006-93E5ACAB-859C-4BBC-BA69-8E3C1E4944F6Q52447526-724EB5B3-A8D1-4C9D-ACED-08089F3D18A4Q52729539-405F2F16-3234-45C8-81F1-6FCC21FC90E2Q55130392-0E1A5129-A152-4690-8F12-D4C230AACC6AQ55147541-C3B7E1CD-5EDB-4257-B949-C14F3CA1DB66Q55333411-27137429-E834-48B6-9FCF-736E70D2C135Q59136338-3B8DA063-B80E-40FB-84E7-0D6FCFD913FF
P2860
Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Early Components of the Comple ...... n Systemic Autoimmune Diseases
@ast
Early Components of the Comple ...... n Systemic Autoimmune Diseases
@en
Early Components of the Comple ...... n Systemic Autoimmune Diseases
@nl
type
label
Early Components of the Comple ...... n Systemic Autoimmune Diseases
@ast
Early Components of the Comple ...... n Systemic Autoimmune Diseases
@en
Early Components of the Comple ...... n Systemic Autoimmune Diseases
@nl
prefLabel
Early Components of the Comple ...... n Systemic Autoimmune Diseases
@ast
Early Components of the Comple ...... n Systemic Autoimmune Diseases
@en
Early Components of the Comple ...... n Systemic Autoimmune Diseases
@nl
P2093
P2860
P3181
P356
P1476
Early Components of the Comple ...... n Systemic Autoimmune Diseases
@en
P2093
Charles H Spencer
Georges Hauptmann
John P Atkinson
Katherine E Lintner
Lee A Hebert
Yee Ling Wu
P2860
P3181
P356
10.3389/FIMMU.2016.00036
P407
P577
2016-01-01T00:00:00Z